Confocal Microscopy to Check Prostate Cancer Surgery Margins
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether a special microscope can help surgeons see cancer margins (edges) during prostate removal surgery to make sure all cancer is removed. It may help surgeons make real-time decisions about how much tissue to remove.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with prostate cancer that has spread locally (stages T2-T3a) but not to lymph nodes or distant sites
- Healthy enough to have robot-assisted prostate removal surgery
- Your surgical team has decided not to try to preserve nerves on at least one side of your prostate based on imaging and biopsy results
- Able to read English and understand the study information to give informed consent
- Have not received hormone therapy (ADT) before surgery
- Have not had previous prostate cancer treatment like radiation, chemotherapy, or focal therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging technology during prostate cancer surgery to help surgeons see cancer edges more clearly in real time. The goal is to make sure all cancer is removed while protecting nearby healthy tissue.
This study tests if a special microscope called confocal laser endomicroscopy can help doctors check for leftover cancer cells faster during prostate removal surgery. It is for patients with intermediate or high-risk prostate cancer who are scheduled for robot-assisted prostate removal and have not had prior treatment.
This trial tests a laser treatment that targets only the cancerous part of the prostate. It may be an option for men with intermediate-risk prostate cancer who do not want their entire prostate removed.
This trial compares two nerve-sparing techniques during robotic prostatectomy to see which better preserves urinary and sexual function while still effectively removing the cancer. It is for men with early-stage, favorable-risk prostate cancer who are good surgical candidates.
This trial tests whether a precisely targeted laser procedure—guided by MRI images—can treat prostate cancer. It may help some men who have a certain type and location of tumor while aiming to avoid nearby sensitive structures.
This study tests a new device that uses tiny electrical sensors to help surgeons check if all the cancer has been removed during prostate cancer surgery. It could give real-time feedback so the surgeon can remove leftover cancer right away.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.